Department of Metabolism, Endocrinology and Molecular Medicine, Internal Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan,
Osteoporos Int. 2013 Nov;24(11):2863-70. doi: 10.1007/s00198-012-2245-x. Epub 2013 Sep 13.
We reported previously that serum parathyroid hormone [PTH(1-84)]/intact PTH[PTH(1-84) + PTH(7-84)] ratio provides the better marker for parathyroid function and bone turnover state than serum PTH level itself. The present study demonstrated that higher PTH(1-84)/intact PTH ratio, but not serum PTH(1-84) and intact PTH, predicted higher all-cause mortality in 177 male hemodialysis patients.
We reported that PTH(1-84)/intact PTH ratio provides a clinically relevant marker for parathyroid function and the resultant bone turnover state. The purpose of our study was to investigate the association of PTH(1-84)/intact PTH ratio with all-cause mortality (ACM) in male hemodialysis patients.
The study was performed for 70 months. Serum PTH in 177 male hemodialysis patients was measured with PTH(1-84)-specific whole PTH assay and intact PTH assay which cross-reacts with N-truncated PTH including PTH(7-84).
The patients (n = 177) were divided into higher and lower halves based on serum levels of PTH(1-84)/intact PTH ratio (cutoff value, 0.484), intact PTH (143.8 pg/mL), and PTH(1-84) (64.1 pg/mL). In Kaplan-Meier analysis, the higher group in whole PTH/intact PTH ratio had significantly higher ACM than the lower group (P = 0.020 by log-rank test), in contrast with the insignificant difference between the higher and lower groups in intact PTH and PTH(1-84). Multivariate Cox regression hazard analysis identified higher log [PTH(1-84)/intact PTH ratio], but not log intact PTH or log PTH(1-84) as a significant independent predictor [hazard ratio 14.428 (95% CI 2.486-83.728)] for ACM after adjustment for various factors including age, hemodialysis duration, presence/absence of diabetes mellitus, BMI, log C-reactive protein, serum albumin, calcium, and phosphate. The association existed between log [PTH(1-84)/intact PTH ratio] and ACM in those without vitamin D administration (n = 95).
Higher PTH(1-84)/intact PTH ratio, which provides a relevant marker for parathyroid function, may be a significant predictor of ACM in male hemodialysis patients.
我们报道过,甲状旁腺激素(PTH)[1-84]与完整 PTH(PTH [1-84] + PTH [7-84])比值比血清 PTH 水平本身更能反映甲状旁腺功能和骨转换状态。本研究表明,较高的 PTH [1-84]/完整 PTH 比值,而非血清 PTH [1-84]和完整 PTH,可预测 177 例男性血液透析患者的全因死亡率(ACM)更高。
研究进行了 70 个月。用 PTH [1-84]-特异性全 PTH 检测法和完整 PTH 检测法(与包括 PTH [7-84]在内的 N 端截断的 PTH 有交叉反应)测定 177 例男性血液透析患者的血清 PTH。
根据血清 PTH [1-84]/完整 PTH 比值(截断值为 0.484)、完整 PTH(143.8 pg/ml)和 PTH [1-84](64.1 pg/ml)水平,将患者(n = 177)分为较高和较低两组。在 Kaplan-Meier 分析中,高组的全 PTH/完整 PTH 比值的 ACM 显著高于低组(对数秩检验,P = 0.020),而完整 PTH 和 PTH [1-84]的高组和低组之间无显著性差异。多变量 Cox 回归风险分析确定,较高的 log [PTH [1-84]/完整 PTH 比值],而不是 log 完整 PTH 或 log PTH [1-84],是 ACM 的独立显著预测因子[风险比 14.428(95%CI 2.486-83.728)],在调整了年龄、血液透析持续时间、是否存在糖尿病、BMI、C 反应蛋白、血清白蛋白、钙和磷等多种因素后。在未接受维生素 D 治疗的患者(n = 95)中,log [PTH [1-84]/完整 PTH 比值]与 ACM 之间存在关联。
较高的 PTH [1-84]/完整 PTH 比值,是甲状旁腺功能的一个相关标志物,可能是男性血液透析患者 ACM 的一个重要预测因子。